Literature DB >> 10352923

Insulin action in the normal and polycystic ovary.

S Franks1, C Gilling-Smith, H Watson, D Willis.   

Abstract

Insulin has a stimulatory effect on steroidogenesis by granulosa cells of normal and polycystic ovaries and interacts with gonadotropins in an additive or, as in the case of LH, a synergistic manner. These actions seem to be mediated specifically by the insulin receptor rather than by cross-reaction with the type I IGF receptor, even in tissue obtained from women with PCOS with biochemical evidence of insulin resistance. The authors suggest that hyperinsulinemia makes a significant contribution to premature arrest of follicle growth, which is characteristic of anovulation in women with PCOS, and that the interaction of insulin with LH is a key element in this process. Insulin may also have a role in amplifying LH-induced androgen production by theca cells, which may help explain the prominence of symptoms of hyperandrogenism in obese subjects with PCOS. The results of recent clinical studies of insulin-sensitizing agents such as metformin and the thiazoladinedione troglitazone in PCOS have provided encouragement that improvement of insulin sensitivity and consequent lowering of circulating insulin levels by these agents may be of therapeutic value in the management of both anovulation and hirsutism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10352923     DOI: 10.1016/s0889-8529(05)70074-8

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  49 in total

Review 1.  Multiple signal transduction pathways regulate ovarian steroidogenesis.

Authors:  Jennifer R Wood; Jerome F Strauss
Journal:  Rev Endocr Metab Disord       Date:  2002-01       Impact factor: 6.514

Review 2.  The ovarian androgen-producing cells: a 2001 perspective.

Authors:  Denis A Magoffin
Journal:  Rev Endocr Metab Disord       Date:  2002-01       Impact factor: 6.514

3.  Interventional studies for polycystic ovarian syndrome in children and adolescents.

Authors:  Patricia Myriam Vuguin
Journal:  Ped Health       Date:  2010-02

4.  Glucose-stimulated oxidative stress in mononuclear cells is related to pancreatic β-cell dysfunction in polycystic ovary syndrome.

Authors:  Steven K Malin; John P Kirwan; Chang Ling Sia; Frank González
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

5.  Differential effects of insulin sensitivity on androgens in obese women with polycystic ovary syndrome or normal ovulation.

Authors:  Tomoko Asagami; Tyson H Holmes; Gerald Reaven
Journal:  Metabolism       Date:  2008-10       Impact factor: 8.694

Review 6.  Nonalcoholic fatty liver disease and polycystic ovary syndrome.

Authors:  Evangeline Vassilatou
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

7.  The efficacy of metformin in pregnant women with polycystic ovary syndrome: a meta-analysis of clinical trials.

Authors:  J Zheng; P F Shan; W Gu
Journal:  J Endocrinol Invest       Date:  2013-04-12       Impact factor: 4.256

Review 8.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

9.  Rapid and easy assessment of insulin resistance contributes to early detection of polycystic ovary syndrome.

Authors:  M Rizzo; E K Tyndall; S Frontoni; F Jacoangeli; F Sarlo; F Panebianco; A Mistorni; L Di Renzo; R Calafiore; G Luca; A De Lorenzo
Journal:  J Endocrinol Invest       Date:  2013-04-23       Impact factor: 4.256

Review 10.  Ontogeny of the ovary in polycystic ovary syndrome.

Authors:  Daniel A Dumesic; Joanne S Richards
Journal:  Fertil Steril       Date:  2013-03-06       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.